Silence Therapeutics (SLN) Non-cash Items (2022 - 2026)

Silence Therapeutics' Non-cash Items history runs 5 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 32.06% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (up 32.06% YoY), while the FY2025 annual figure was $6.0 million, up 109.05% from the prior year.
• Non-cash Items came in at $4.5 million for Q1 2026 at Silence Therapeutics, down from $6.0 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $6.0 million in Q4 2025 to a low of $2.2 million in Q4 2022.
• A 5-year average of $3.7 million and a median of $3.6 million in 2025 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items declined 4.47% in 2024 and jumped 109.05% in 2025, its largest moves.
• Silence Therapeutics' Non-cash Items stood at $2.2 million in 2022, then surged by 35.56% to $3.0 million in 2023, then declined by 4.47% to $2.9 million in 2024, then soared by 109.05% to $6.0 million in 2025, then retreated by 24.95% to $4.5 million in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $4.5 million, $6.0 million, and $4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison